Rheumatoid Arthritis Patients’ Motivations for Accepting or Resisting Disease-Modifying Antirheumatic Drug Treatment Regimens-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Rheumatoid Arthritis Patients’ Motivations for Accepting or Resisting Disease-Modifying Antirheumatic Drug Treatment Regimens

Published:2018-03-11 Issue:4 Volume:70 Page:533-541
ISSN:2151-464X
Container-title:Arthritis Care & Research
language:en
Short-container-title:Arthritis Care Res

Author:

Shaw Yomei¹,Metes Ilinca D.¹,Michaud Kaleb²,Donohue Julie M.¹,Roberts Mark S.¹,Levesque Marc C.³,Chang Judy C.⁴

Affiliation:

1. University of Pittsburgh Graduate School of Public Health; Pittsburgh Pennsylvania

2. University of Nebraska Medical Center; Omaha, and National Data Bank for Rheumatic Diseases; Wichita Kansas

3. AbbVie; Worcester Massachusetts

4. University of Pittsburgh School of Medicine; Pittsburgh Pennsylvania

Funder

Genentech

Publisher

Wiley

Subject

Rheumatology

Reference50 articles.

1. Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force;Smolen;Ann Rheum Dis,2016

2. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update;Smolen;Ann Rheum Dis,2017

3. 2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis;Singh;Arthritis Care Res (Hoboken),2016

4. Use of disease-modifying medications for rheumatoid arthritis by race and ethnicity in the National Ambulatory Medical Care Survey;Solomon;Arthritis Care Res (Hoboken),2012

5. Receipt of disease-modifying antirheumatic drugs among patients with rheumatoid arthritis in Medicare managed care plans;Schmajuk;JAMA,2011

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Association between the Response to Rituximab with Sociodemographic Data and Disease Characteristics Among a Sample of Iraqi Patients with Rheumatoid Arthritis;Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 );2024-09-14

2. Sulfasalazine promotes ferroptosis through AKT-ERK1/2 and P53-SLC7A11 in rheumatoid arthritis;Inflammopharmacology;2024-02-26

3. The Gap in Knowledge about Tapering Targeted Therapy being used as Monotherapy in Rheumatoid Arthritis: A Systematic Review;Current Rheumatology Reviews;2024-02

4. Comparison of time to clinically meaningful improvement in quality of life in neurological disorders in patients treated with natalizumab versus ocrelizumab;Neurodegenerative Disease Management;2024-01-02

5. Self-regulatory coping among community dwelling older adults with multiple chronic conditions;Journal of Multimorbidity and Comorbidity;2023-10-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3